Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan

BMC Gastroenterology

Tao-Hsin Tung²  Jorn-Hon Liu³  Chung-Te Hsu⁴  Jau-Yuan Chen¹ 

[1] Department of Family Medicine, Linkou Chang-Gung Memorial Hospital and Chang-Gung University, Taoyuan, Taiwan;Cheng Hsin General Hospital; Faculty of Public Health, School of Medicine, Fu-Jen Catholic University, Taipei, Taiwan;Cheng Hsin General Hospital; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan;Cheng Hsin General Hospital, Taipei, Taiwan

关键词: Screening;    Predictive factors;    Incidence density;    Gallstone disease (GSD);    Follow-up study;   

Others  :  855323
DOI  :  10.1186/1471-230X-14-83

 received in 2013-03-09, accepted in 2014-04-23,  发布年份 2014

【 摘 要 】

Background

Gallstone disease (GSD) is a common gastrointestinal disorder throughout the world. The authors explored the incidence of GSD in Taiwan and its condition-associated predictive factors.

Methods

The initial study cohort comprised 2386 healthy adult participants, who were voluntarily admitted to a teaching hospital for a physical check-up in 2002 in Taipei, Taiwan. After excluding 126 patients who exhibited prevalent GSD, 2260 non-GSD participants received annual follow-up screenings for GSD until 31 December, 2007. Of those, 1296 (57.3%) patients were re-examined to collect blood samples and conduct ultrasound sonography.

Results

Among the 1296 participants who exhibited no GSD at the first screening, 23 patients developed GSD during 3640 person-years of follow-up. The incidence was 0.632% per year (95% CI: 0.292%–2.009%). After conducting a Cox regression, increased age (50–59 years versus < 40 years, RR = 2.16 [95% CI: 1.09–5.97], 60+ years versus < 40 years, RR = 3.81 [95% CI: 2.77–8.63]), high body mass index (≥27 kg/m² versus < 24 kg/m², RR = 1.64 [95% CI: 1.07–2.98]), high fasting plasma glucose levels (≥126 mg/dL versus < 110 mg/dL, RR = 1.68, 95% CI: 1.10–3.87), and nonalcoholic fatty liver disease (yes versus no, RR = 1.44, 95% CI: 1.21–1.90) appeared to be significantly related to developing GSD.

Conclusion

Increased age is a well-established risk factor for developing GSD. The current findings indicated that high body mass index, elevated fasting plasma glucose levels, and nonalcoholic fatty liver disease were also associated with GSD.

【 授权许可】

   
2014 Chen et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Everhart JE, Khare M, Hill M, Maurer KR: Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterol 1999, 117:632. PMID: 10464139
• [2]Festi D, Dormi A, Capodicasa S, Staniscia T, Attili AF, Loria P, Pazzi P, Mazzella G, Sama C, Roda E, Colecchia A: Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol 2008, 14:5282-5289. PMID: 18785280
• [3]Liu CM, Tung TH, Chou P, Chen VT, Hsu CT, Chien WS, Lin YT, Lu HF, Shih HC, Liu JH: Clinical correlation of gallstone disease in a Chinese population in Taiwan: experience at Cheng Hsin General Hospital. World J Gastroenterol 2006, 12:1281-1286. PMID: 16534886
• [4]Shaffer EA: Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 2005, 7:132-140. PMID: 15802102
• [5]Stinton LM, Myers RP, Shaffer EA: Epidemiology of gallstones. Gastroenterol Clin North Am 2010, 39:157-169. vii [PMID: 20478480]
• [6]Hsu CT, Lien SY, Jiang YD, Liu JH, Shih HC, Tung TH: Screening gallstone disease by ultrasound decreases the necessity of cholecystectomy. Asia Life Sci 2013, 22:51-60.
• [7]American Diabetes Association: American Diabetes Association: clinical practice recommendations 1999. Diabetes Care 1999, 22:S1-S114. PMID: 10333970
• [8]Wang CS, Wang ST, Chang TT, Yao WJ, Chou P: Smoking and alanine aminotransferase levels in hepatitis C virus infection: Implications for prevention of hepatitis C virus progression. Arch Intern Med 2002, 162:811-815. PMID: 11926856
• [9]Dai HF, Shen Z, Yu CH, Zhang XC, Li YM: Epidemiology of fatty liver in an islander population of China: a population-based case–control study. Hepatobiliary Pancreat Dis Int 2008, 7:373-378. PMID: 18693172
• [10]Lin YC, Chou SC, Huang PT, Chiou HY: Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan. Ann Hepatol 2011, 10:125-132. PMID: 21502673
• [11]Mogensen NB, Madsen M, Stage P, Mazten P, Malchow-Moller A, Lejerstofte J, Uhrenholdt A: Ultrasonography versus roentenography in suspected instances of cholelithiasis. Surg Gynecol Obstet 1984, 159:353-356. PMID: 6385312
• [12]Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL: Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr 2004, 80:38-44. [PMID: 15213025]
• [13]Angelico F, Del Ben M, Barbato A, Conti R, Urbinati G: Ten-year incidence and natural history of gallstone disease in a rural population of women in central Italy. The Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO). Ital J Gastroenterol Hepatol 1997, 29:249-254. PMID: 9646217
• [14]Byrt T: How good is that agreement? Epidemiology 1996, 7:561. PMID: 8862998
• [15]Shaffer EA: Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006, 20:981-996. PMID: 17127183
• [16]Völzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, John U, Lerch MM: Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005, 71:97-105. [PMID: 15775677]
• [17]Chen CY, Lu CL, Huang YS, Tam TN, Chan Y, Chang FY, Lee SD: Age is one of the risk factors in developing gallstone disease in Taiwan. Age Ageing 1998, 27:437-441. PMID: 9883999
• [18]Tung TH, Ho HM, Shih HC, Chou P, Liu JH, Chen VT, Chan DC, Liu CM: A population-based follow-up study on gallstone disease among type 2 diabetics in Kinmen, Taiwan. World J Gastroenterol 2006, 12:4536-4540. PMID: 16874867
• [19]Liu CM, Tung TH, Liu JH, Tsai YK, Chen VTK, Tam TN, Lu HF, Wang KK, Hsu CT, Chou P: Serum insulin, insulin resistance, β-cell dysfunction, and gallstone disease among type 2 diabetics in Chinese population: A community-based study in Kinmen, Taiwan. World J Gastroenterol 2005, 11:7159-7164. PMID: 16437664
• [20]Forari F, Imberti D, Squillante MM, Squassante L, Civardi G, Buscarini E, Cavanna L, Caturelli E, Buscarini L: Incidence of gallstones in a population of patients with cirrhosis. J Hepat 1994, 20:797-801. PMID: 7930481
• [21]Olmo JAD, Garcia F, Serra MA, Maldonado L, Rodrigo JM: Prevalence and incidence of gallstones in liver cirrhosis. Scand J Gastroenterol 1997, 32:1061-1065. PMID: 9361181
• [22]Kaplan MM: Alanine aminotransferase levels: what's normal? Ann Intern Med 2002, 137:49-51. PMID: 12093245
• [23]Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, Younossi ZM, Schwimmer JB: Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008, 103:2263-2271. [PMID: 18684196]
• [24]Fan JG, Li F, Cai XB, Peng YD, Ao QH, Gao Y: The important of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J Gastroenterol Hepatol 2007, 22:663-668. [PMID: 17444853]
• [25]Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, Yueh SK: Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol 2007, 22:1482-1489. PMID: 17716352
• [26]Yener O, Aksoy F, Demır M, Özçelık A, Erengül C: Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome. Turk J Gastroenterol 2010, 21:411-415. [PMID: 21331995]